Cantor Fitzgerald

Progyny’s Stock Target Increased to $25 by JPMorgan Chase

Progyny, Inc. (NASDAQ: PGNY) has seen its price target raised from $23.00 to $25.00 by analysts at JPMorgan Chase & Co., as reported on...

Editorial27 August, 2025

Meta Platforms (NASDAQ: META) received an upgraded price target of $850.00 from Morgan Stanley in a report published on July 30, 2023. This marks...

Editorial3 August, 2025

Merck & Co., Inc. (NYSE: MRK) has seen its price target adjusted downward by Morgan Stanley from $99.00 to $98.00, according to a research...

Editorial11 July, 2025